241. Thin melanoma and sentinel lymph node biopsy: A difficult relationship between them. Issue 6 (2016) Authors: Otero, JC Rodriguez; Bussy, R Fernandez; Bergero, A; Gorosito, M; Salerni, G Journal: Integrative cancer science and therapeutics Issue: Volume 3:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
242. Toll-like receptors and breast cancer. Issue 2 (2016) Authors: Sun, Lijie; Jiang, Qiuli; Liang, Hongbin; Ren, Huan; Zhang, Dekai Journal: Integrative cancer science and therapeutics Issue: Volume 3:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
243. Topical administration of a newly devised anticancer agent: A novel concept of cancer chemotherapy. Issue 3 (2014) Authors: Sugitachi, Akio; Takahashi, Naoko; Kume, Kohei; Ohmori, Yukimi; Nishizuka, Satoshi; Kimura, Yusuke; Wakabayashi, Go Journal: Integrative cancer science and therapeutics Issue: Volume 1:Issue 3(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
244. Towards an integrated model of defense in gynecological cancer. Psychoneuroimmunological and psychological factors, between risk and protection in cancer: A review. Issue 2 (2015) Authors: Cosentino, Chiara; Pruneti, Carlo A. Journal: Integrative cancer science and therapeutics Issue: Volume 2:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
245. Translocations involving ETS family proteins in human cancer. Issue 4 (2018) Authors: Fry, Elizabeth A; Mallakin, Ali; Inoue, Kazushi Journal: Integrative cancer science and therapeutics Issue: Volume 5:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
246. Trastuzumab emtansine is the standard second-line treatment following horizontal blockade in first line of advanced HER-2 positive breast cancer: A plant that has still to grow. Issue 1 (2019) Authors: Montella, Liliana; Prete, Salvatore Del; Bove, Pasquale Journal: Integrative cancer science and therapeutics Issue: Volume 6:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
247. Tumor heterogeneity An overlooked issue in cancer therapeutics. Issue 2 (2017) Authors: Koltai, Tomas Journal: Integrative cancer science and therapeutics Issue: Volume 4:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
248. Two subpopulations of progenitors of leukemic lineages in human myeloid leukemias exhibit different heterochromatin condensation state in central and peripheral nuclear regions (A morphological note with additional original observations). Issue 4 (2020) Authors: Smetana, Karel; Klamová, Hana; Mikulenková, Dana; Schwarz, Jiří Journal: Integrative cancer science and therapeutics Issue: Volume 7:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
249. Typical versus atypical antipsychotics: Genotoxicity and cytostaticity testing. Issue 3 (2020) Authors: Katsioulis, Evangelos G; Argyraki, Maria; Ekonomopoulou, Maria T; Mourelatos, Constantine; Iakovidou-Kritsi, Zafiroula; Mourelatos, Dionysios Journal: Integrative cancer science and therapeutics Issue: Volume 7:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
250. Understanding cancer breakpoint determinants with omics data. Issue 2 (2020) Authors: Cheloshkina, Kseniia; Poptsova, Maria Journal: Integrative cancer science and therapeutics Issue: Volume 7:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗